当前位置:首页 - 行情中心 - 华海药业(600521) - 财务分析

华海药业

(600521)

  

流通市值:227.49亿  总市值:227.49亿
流通股本:14.67亿   总股本:14.67亿

华海药业(600521)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润10.37亿元,每股收益0.71元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益895494.85万元,未分配利润546766.78万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产1955518.98万元,负债1060024.13万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入7,247,654,219.75,128,307,063.042,498,671,124.158,308,719,758.46
营业总成本5,940,775,917.634,142,622,747.052,099,036,620.377,096,899,572.91
营业利润1,316,952,527.66957,481,742.99374,627,295.81,124,539,623.55
利润总额1,311,263,170.14956,425,345.5371,845,376.741,100,321,379.94
净利润1,037,247,794.71754,349,946.71273,944,434.55817,249,345.21
其他综合收益-6,120,263.49516,199.63-493,321.795,124,020.47
综合收益总额1,031,127,531.22754,866,146.34273,451,112.76822,373,365.68
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计7,980,130,228.568,120,384,717.038,901,797,081.577,621,698,796.25
非流动资产合计11,575,059,548.7711,393,060,233.2511,187,520,098.2910,978,270,816.59
资产总计19,555,189,777.3319,513,444,950.2820,089,317,179.8618,599,969,612.84
流动负债合计5,683,769,186.075,713,445,596.166,703,387,411.925,445,255,330.94
非流动负债合计4,916,472,122.584,835,695,607.844,895,855,335.944,903,599,341.63
负债合计10,600,241,308.6510,549,141,20411,599,242,747.8610,348,854,672.57
归属于母公司股东权益合计8,792,525,623.878,802,460,428.428,319,436,460.318,076,851,901.19
股东权益合计8,954,948,468.688,964,303,746.288,490,074,4328,251,114,940.27
负债和股东权益合计19,555,189,777.3319,513,444,950.2820,089,317,179.8618,599,969,612.84
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计7,606,205,640.35,057,445,018.742,724,454,394.39,268,713,485.5
经营活动现金流出小计5,728,821,853.173,759,617,504.941,871,208,351.277,051,692,210.62
经营活动产生的现金流量净额1,877,383,787.131,297,827,513.8853,246,043.032,217,021,274.88
投资活动现金流入小计9,048,365.038,059,223.66,597,601.1456,671,337.34
投资活动现金流出小计1,194,336,249.1823,470,589.8478,288,260.591,679,442,245.91
投资活动产生的现金流量净额-1,185,287,884.07-815,411,366.2-471,690,659.45-1,622,770,908.57
筹资活动现金流入小计4,012,608,0102,986,057,6001,838,330,0003,320,500,000
筹资活动现金流出小计4,618,819,743.263,283,064,162.92745,298,540.593,964,732,023.53
筹资活动产生的现金流量净额-606,211,733.26-297,006,562.921,093,031,459.41-644,232,023.53
汇率变动对现金及现金等价物的影响669,731.6943,769,991.6310,975,693.5328,997,894.61
现金及现金等价物净增加额86,553,901.49229,179,576.311,485,562,536.52-20,983,762.61
期末现金及现金等价物余额1,393,520,264.221,536,145,939.042,792,528,899.251,306,966,362.73
最新报告期:2024-11-21
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
招商证券梁广楷,许菲菲0.891.091.332024-11-21
TOP↑